| RS61745653 |
ATL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS61745707 |
ALDH6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonate semialdehyde dehydrogenase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency |
| RS61745752 |
GPR68
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta, hypomaturation type |
| RS61745803 |
CSNK2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61745877 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Inborn genetic diseases |
| RS61745973 |
SNIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
SNIP1-related disorder, SNIP1-related disorder |
| RS61746008 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS61746119 |
DONSON
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61746139 |
TTC7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple gastrointestinal atresias, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS61746197 |
-
|
Health Risk |
Conflicting classifications of pathogenicity |
Radial aplasia-thrombocytopenia syndrome, GPR89B-related condition |
| RS61746297 |
ANO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, Dystonia 24 |
| RS61746358 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS61746359 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS61746426 |
NEK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, Perthes disease |
| RS61746533 |
ERCC6L2
|
Health Risk |
Conflicting classifications of pathogenicity |
ERCC6L2-related disorder, Inborn genetic diseases |
| RS61746582 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DNAH9-related disorder |
| RS61746591 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS61746596 |
ALKBH8
|
Health Risk |
Conflicting classifications of pathogenicity |
ALKBH8-related disorder, ALKBH8-related disorder |
| RS61746642 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS61746653 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS61746686 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS61746816 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS61746928 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS61747068 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS61747281 |
SEPSECS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 2D, Pontocerebellar hypoplasia type 2D |
| RS61747283 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS61747284 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61747288 |
ADA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of adenosine deaminase 2, Sneddon syndrome |
| RS61747367 |
VSX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 2, Microphthalmia |
| RS61747461 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS61747592 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT1-related disorder, FAT1-related disorder |
| RS61747607 |
GNB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Clear cell carcinoma of kidney |
| RS61747625 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS61747635 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS61747727 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS61747728 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Proteinuria, Nephrotic syndrome |
| RS61748081 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS61748083 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS61748106 |
UBA5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS61748123 |
SRD5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS61748127 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS61748158 |
BIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, centronuclear |
| RS61748230 |
RIF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61748364 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease type 4 |
| RS61748373 |
ARFGEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS61748383 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Inborn genetic diseases |
| RS61748384 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748389 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748390 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748391 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Inborn genetic diseases |
| RS61748392 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked intellectual disability-psychosis-macroorchidism syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748393 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748395 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748396 |
MECP2
|
Health Risk |
Pathogenic |
Atypical Rett syndrome, Angelman syndrome |
| RS61748398 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748399 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS61748400 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS61748402 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748403 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748404 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748406 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748407 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS61748408 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748410 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Rett syndrome |
| RS61748411 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748414 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism, susceptibility to |
| RS61748415 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748416 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748417 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748418 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748420 |
MECP2
|
Health Risk |
Pathogenic |
X-linked intellectual disability-psychosis-macroorchidism syndrome, Rett syndrome |
| RS61748421 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Intellectual disability |
| RS61748425 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS61748426 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, Inborn genetic diseases |
| RS61748428 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS61748429 |
PRPH2
|
Health Risk |
Pathogenic |
Patterned macular dystrophy 1, Retinal dystrophy |
| RS61748430 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult-onset foveomacular vitelliform dystrophy, Vitelliform macular dystrophy 2 |
| RS61748432 |
PRPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
PRPH2-related disorder, Choroidal dystrophy |
| RS61748433 |
PRPH2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 7, PRPH2-related disorder |
| RS61748434 |
PRPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult-onset foveomacular vitelliform dystrophy, Patterned macular dystrophy 1 |
| RS61748436 |
CRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS61748437 |
CRX
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 7, Cone-rod dystrophy 2 |
| RS61748442 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 7 |
| RS61748444 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Cone-rod dystrophy 2 |
| RS61748446 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Leber congenital amaurosis 7 |
| RS61748449 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Cone-rod dystrophy 2 |
| RS61748451 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 2 |
| RS61748452 |
CRX
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 7, Cone-rod dystrophy 2 |
| RS61748455 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS61748460 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS61748462 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS61748463 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS61748464 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS61748465 |
VWF
|
Health Risk |
Pathogenic/Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS61748466 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 2, von Willebrand disease type 3 |
| RS61748467 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS61748476 |
VWF
|
Health Risk |
Pathogenic |
— |
| RS61748477 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 2N, Abnormal bleeding |
| RS61748478 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 2N, von Willebrand disease type 2N |
| RS61748480 |
VWF
|
Health Risk |
Pathogenic/Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |